Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis

Epigenomics

Volumn 5, Issue 2, 2013, Pages 155-165

  Mitchell, Natalie E ^a   Wilson, Mackenzie L ^a   Bray, Molly S ^a   Crossman, David K ^b   Tollefsbol, Trygve O ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

breast cancer; DNA methylation; epigenetics; Illumina Infinium HumanMethylation27 BeadChip; neoplastic reprogramming

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MOTION; CHROMOSOME ABERRATION; CPG ISLAND; DISEASE COURSE; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR REPROGRAMMING; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PYROSEQUENCING;

BREAST NEOPLASMS; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME, HUMAN; HUMANS; MAMMARY GLANDS, HUMAN; NUCLEAR REPROGRAMMING;

EID: 84876137449     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.6     Document Type: Article

References (41)

1. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J. Clin. 61(6), 409-418 (2011).
2. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 400(6743), 464-468 (1999). (Pubitemid 29361801)
3. Casillas MA, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316, 57-65 (2003). (Pubitemid 37249353)
4. Liu J, Yang G, Thompson-Lanza JA et al. A genetically defined model for human ovarian cancer. Cancer Res. 64(5), 1655-1663 (2004). (Pubitemid 38428686)
5. Elenbaas B, Spirio L, Koerner F et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15(1), 50-65 (2001). (Pubitemid 32060682)
6. DeAngelis JT, Li Y, Mitchell N, Wilson L, Kim H, Tollefsbol TO. 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. J. Proteome Res. 10(2), 447-458 (2011).
7. Katto J, Mahlknecht U. Epigenetic regulation of cellular adhesion in cancer. Carcinogenesis 32(10), 1414-1418 (2011).
8. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11(10), 726-734 (2011).
9. Doi A, Park IH, Wen B et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41(12), 1350- 1353 (2009).
10. Irizarry RA, Ladd-Acosta C, Wen B et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41(2), 178-186 (2009).
11. Anderson RM, Bosch JA, Goll MG et al. Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev. Biol. 334(1), 213-223 (2009).
12. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349(21), 2042-2054 (2003). (Pubitemid 37448928)
13. Bibikova M, Le J, Barnes B et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1(1), 177-200 (2009).
14. Sun Z, Chai HS, Wu Y et al. Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med. Genomics 4, 84 (2011).
15. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100(16), 9440-9445 (2003). (Pubitemid 37033947)
16. Rajendram R, Ferreira JC, Grafodatskaya D et al. Assessment of methylation level prediction accuracy in methyl-DNA immunoprecipitation and sodium bisulfite based microarray platforms. Epigenetics 6(4), 410-415 (2011).
17. Hanna CW, Bloom MS, Robinson WP et al. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum. Reprod. 27(5), 1401-1410 (2012).
18. Shen J, Wang S, Zhang YJ et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 55(6), 1799-1808 (2012).
19. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8(4), 286-298 (2007). (Pubitemid 46439286)
20. Holliday R. Epigenetics: a historical overview. Epigenetics 1(2), 76-80 (2006).
21. Herman JG, Merlo A, Mao L et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55(20), 4525-4530 (1995).
22. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428 (2002). (Pubitemid 34587077)
23. Bernardino J, Roux C, Almeida A et al. DNA hypomethylation in breast cancer: an independent parameter of tumor progression? Cancer Genet. Cytogenet. 97(2), 83-89 (1997). (Pubitemid 27362497)
24. Soares J, Pinto AE, Cunha CV et al. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 85(1), 112-118 (1999). (Pubitemid 29031364)
25. Veeck J, Esteller M. Breast cancer epigenetics: from DNA methylation to microRNAs. J. Mammary Gland Biol. Neoplasia 15(1), 5-17 (2010).
26. Ruike Y, Imanaka Y, Sato F et al. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11, 137 (2010).
27. Fackler MJ, Umbricht CB, Williams D et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 71(19), 6195-6207 (2011).
28. Tan J, Gu Y, Zhang X et al. Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis. Clin. Exp. Med. 13(1), 1-9 (2012).
29. Park SY, Kwon HJ, Lee HE et al. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 458(1), 73-84 (2011).
30. Alvarez H, Opalinska J, Zhou L et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7(3), e1001356 (2011).
31. Rauch T, Wang Z, Zhang X et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc. Natl Acad. Sci. USA 104(13), 5527-5532 (2007). (Pubitemid 47175714)
32. Novak P, Jensen T, Oshiro MM et al. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res. 66(22), 10664-10670 (2006). (Pubitemid 44876960)
33. Helman E, Naxerova K, Kohane IS. DNA hypermethylation in lung cancer is targeted at differentiation-associated genes. Oncogene 31(9), 1181-1188 (2012).
34. van Vlodrop IJ, Niessen HE, Derks S et al. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin. Cancer Res. 17(13), 4225-4231 (2011).
35. Easwaran H, Johnstone S, Vanneste L et al. A DNA hypermethylation module for the stem/ progenitor cell signature of cancer. Genome Res. 22(5), 837-849 (2012).
36. Mohammad HP, Cai Y, McGarvey KM et al. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res. 69(15), 6322-6330 (2009).
37. Viré E, Brenner C, Deplus R et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078), 871-874 (2006). (Pubitemid 43255707)
38. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40(5), 499-507 (2008). (Pubitemid 351601215)
39. Lee TI, Jenner RG, Boyer LA et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125(2), 301-313 (2006). (Pubitemid 44313811)
40. SEER Cancer Statistics Review 1975-2009. http://seer.cancer.gov/csr/1975- 2009- pops09/
41. Pathway analysis, mRNA, RNA-seq, NGS and microarray. www.ingenuity.com